IDXX$551.214.30%-24.77
After Hours: 538.70-12.51 -2.27%
Idexx Laboratories Inc (IDXX)
Date: 2026-10-30 16:00O: 583.75H: 586.00L: 540.61C: 551.21Vol: 1.113M
Idexx Laboratories Inc stock is traded at $551.21, with a volume of 1,113,221. It is down -4.30% in the last 24 hours and up +5.56% over the past month. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Previous Close:
$575.98
Open:
$583.75
24h Volume:
1,113,221
Relative Volume:
2.17
Market Cap:
$43.42B
Revenue:
$4.45B
Net Income/Loss:
$1.10B
P/E Ratio:
40.56
EPS:
$13.59
Net Cash Flow:
$1.06B
1W Performance:
-1.64%
1M Performance:
+5.56%
6M Performance:
-1.71%
1Y Performance:
-12.30%
1-Day Range:
$540.61$586.00
1-Week Range:
$540.61$586.00
52-Week Range:
$500.61$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
(207) 556-0300Address
ONE IDEXX DRIVE, WESTBROOK, ME, USACompare IDXX vs TMO, DHR, NTRA, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX Idexx Laboratories Inc | $551.21 | $43.42B | $4.45B | $1.10B | $1.06B | $13.59 |
 TMO Thermo Fisher Scientific Inc | $697.00 | $257.71B | $45.20B | $6.87B | $6.75B | $18.19 |
 DHR Danaher Corp | $232.23 | $163.25B | $24.78B | $3.68B | $5.29B | $5.17 |
 NTRA Natera Inc | $414.30 | $59.72B | $2.50B | -$226.32M | $71.51M | -$1.64 |
 A Agilent Technologies Inc | $174.87 | $49.30B | $7.23B | $1.41B | $1.09B | $4.98 |
 WAT Waters Corp | $462.72 | $45.46B | $3.77B | $449.25M | $240.68M | $7.86 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Idexx Laboratories Inc Stock (IDXX) Insider Trading
- LAWRENCE D KINGSLEYSep 04 '26Director
- Transaction
- Proposed Sale
- Cost
- $532.08
- #Shares
- 2,203
- Value ($)
- 1,172,178
- #Shares Total
- 0
- Kingsley Lawrence DSep 04 '26Director
- Transaction
- Sale
- Cost
- $532.08
- #Shares
- 2,203
- Value ($)
- 1,172,178
- #Shares Total
- 9,568
- Emerson AndrewAug 20 '26EVP, CFO and Treasurer
- Transaction
- Option Exercise
- Cost
- $178.26
- #Shares
- 265
- Value ($)
- 47,239
- #Shares Total
- 4,507
- FENNELL GEORGEJun 01 '26Executive Vice President
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 639
- Value ($)
- 0
- #Shares Total
- 10,717
- Margaret Anne SzostakMay 20 '26Director
- Transaction
- Proposed Sale
- Cost
- $553.58
- #Shares
- 1,344
- Value ($)
- 744,012
- #Shares Total
- 0
- Kingsley Lawrence DMay 07 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 339
- Value ($)
- 0
- #Shares Total
- 9,568
- Peacock KarenMay 07 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 101
- Value ($)
- 0
- #Shares Total
- 102
- HOOLEY JOSEPH LMay 07 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 158
- Value ($)
- 0
- #Shares Total
- 276
- Vandebroek Sophie V.May 07 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 257
- Value ($)
- 0
- #Shares Total
- 905
- JUNIUS DANIEL MMay 07 '26Director
- Transaction
- Option Exercise
- Cost
- $0.00
- #Shares
- 257
- Value ($)
- 0
- #Shares Total
- 3,561
